TheraSphere®, Novel Liver Cancer Therapy, Debuts in India

For the first time, MDS Nordion’s innovative primary liver cancer treatment TheraSphere® have been used in India.

MDS Nordion is a leading global provider of medical isotopes and radiopharmaceuticals (used to diagnose and treat diseases) and is one of 89 Ontario-based companies and organizations participating in a trade mission to India, organized by the Government of Ontario.

• Three patients were the first to be treated for primary liver cancer in India using TheraSphere®
• Two of the successful infusions were conducted at the Lilavati Hospital and Research Centre.
• The third was performed at the Jaslok Hospital and Research Centre. Both centres are located in Mumbai, India. TheraSphere® will be used in India to treat both primary and secondary liver cancers.

TheraSphere®, comprised of tiny radioactive glass beads, delivers a therapeutic dose of radiation to cancerous tumours directly by injecting into the main artery of the patient’s liver using a catheter.

Such way minimizes damage to the patient’s healthy tissues unlike conventional cancer therapy.

Find more details from the full report (a pdf file)